Synthesis, cytotoxic, and carbonic anhydrase inhibitory effects of new 2‐(3‐(4‐methoxyphenyl)‐5‐(aryl)‐4,5<scp>‐dihydro‐1<i>H</i></scp>‐pyrazol‐1‐yl)benzo[<i>d</i>]thiazole derivatives
作者:Mehtap Tugrak、Halise Inci Gul、Hiroshi Sakagami、Ilhami Gulcin
DOI:10.1002/jhet.3985
日期:2020.7
2‐(3‐[4‐Methoxyphenyl]‐5‐aryl‐4,5‐dihydro‐1H ‐pyrazol‐1‐yl)benzo[d ]thiazoles (1b‐7b ) were synthesized for the first time except 1b , and spectral methods such as 1H NMR, 13C NMR and HRMS were utilized to illuminate the chemical structures of the synthesized compounds. Phenyl (1b ), 2‐methoxyphenyl (2b ), 4‐methoxyphenyl (3b ), 4‐methoxy‐3‐hydroxyphenyl (4b ), 2,5‐dimethoxyphenyl (5b ), 3,4,5‐trimethoxyphenyl
除1b和1b以外,首次合成了2-(3- [4-甲氧基苯基] -5-芳基-4,5-二氢-1 H-吡唑-1-基)苯并[ d ]噻唑(1b-7b)。光谱方法,例如1 H NMR,13 C NMR和HRMS被用于阐明合成化合物的化学结构。苯基(1b),2-甲氧基苯基(2b),4-甲氧基苯基(3b),4-甲氧基-3-羟基苯基(4b),2,5-二甲氧基苯基(5b),3,4,5-三甲氧基苯基(6b),或噻吩-2-基(7b)用作芳基部分。评估了化合物对人碳酸酐酶I和II酶(hCA I和hCA II)的抑制作用。所述化合物对人类口腔鳞状细胞癌和人类正常口腔细胞的体外细胞毒性作用通过MTT进行。化合物(1b-7b)的Ki值为36.87±11.62-66.24±2.99μM(hCA I)和22.66±1.41-89.95±6.25μM(hCA II)。朝向hCA I的化合物1b(Ki = 36.87±11.62μM